195 related articles for article (PubMed ID: 38163666)
1. Mass spectrometry analysis of intact protein
Xu M; Liu Z; Hu W; Han Y; Wu Z; Chen S; Xia P; DU J; Zhang X; Hao P; Xia J; Yang S
J Zhejiang Univ Sci B; 2024 Jan; 25(1):51-64. PubMed ID: 38163666
[TBL] [Abstract][Full Text] [Related]
2. Mass Spectrometry-Based Analysis of Serum N-Glycosylation Changes in Patients with Parkinson's Disease.
Xu M; Jin H; Wu Z; Han Y; Chen J; Mao C; Hao P; Zhang X; Liu CF; Yang S
ACS Chem Neurosci; 2022 Jun; 13(12):1719-1726. PubMed ID: 35640092
[TBL] [Abstract][Full Text] [Related]
3. Glycoproteomic Approach Identifies KRAS as a Positive Regulator of CREG1 in Non-small Cell Lung Cancer Cells.
Clark DJ; Mei Y; Sun S; Zhang H; Yang AJ; Mao L
Theranostics; 2016; 6(1):65-77. PubMed ID: 26722374
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
Liu L; Qin H; Ye M
Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
[TBL] [Abstract][Full Text] [Related]
5. Site- and structure-specific quantitative N-glycoproteomics study of differential N-glycosylation in MCF-7 cancer cells.
Xue B; Xiao K; Wang Y; Tian Z
J Proteomics; 2020 Feb; 212():103594. PubMed ID: 31759178
[TBL] [Abstract][Full Text] [Related]
6. Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells.
Sudhir PR; Chen CH; Pavana Kumari M; Wang MJ; Tsou CC; Sung TY; Chen JY; Chen CH
Mol Cell Proteomics; 2012 Oct; 11(10):901-15. PubMed ID: 22761399
[TBL] [Abstract][Full Text] [Related]
7. Glycoproteomics Analysis Reveals Differential Expression of Site-Specific Glycosylation in Human Milk Whey during Lactation.
Wang Z; Zhang N; Wang W; Li Y; Szeto IM; Qin H; Jin Y; Ye M
J Agric Food Chem; 2021 Jun; 69(23):6690-6700. PubMed ID: 34087070
[TBL] [Abstract][Full Text] [Related]
8. Mass Spectrometric Analysis of Urinary N-Glycosylation Changes in Patients with Parkinson's Disease.
Xu M; Jin H; Ge W; Zhao L; Liu Z; Guo Z; Wu Z; Chen J; Mao C; Zhang X; Liu CF; Yang S
ACS Chem Neurosci; 2023 Sep; 14(18):3507-3517. PubMed ID: 37677068
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry-based N-linked glycomic profiling as a means for tracking pancreatic cancer metastasis.
Park HM; Hwang MP; Kim YW; Kim KJ; Jin JM; Kim YH; Yang YH; Lee KH; Kim YG
Carbohydr Res; 2015 Sep; 413():5-11. PubMed ID: 26057990
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic Acid Inhibits
Chiu CF; Hsu MI; Yeh HY; Park JM; Shen YS; Tung TH; Huang JJ; Wu HT; Huang SY
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801246
[TBL] [Abstract][Full Text] [Related]
11. Click-iG: Simultaneous Enrichment and Profiling of Intact N-linked, O-GalNAc, and O-GlcNAcylated Glycopeptides.
Liu J; Cheng B; Fan X; Zhou X; Wang J; Zhou W; Li H; Zeng W; Yang P; Chen X
Angew Chem Int Ed Engl; 2023 Sep; 62(36):e202303410. PubMed ID: 37431278
[TBL] [Abstract][Full Text] [Related]
12. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.
Pan S; Chen R; Tamura Y; Crispin DA; Lai LA; May DH; McIntosh MW; Goodlett DR; Brentnall TA
J Proteome Res; 2014 Mar; 13(3):1293-306. PubMed ID: 24471499
[TBL] [Abstract][Full Text] [Related]
13. Glycoproteins and glycoproteomics in pancreatic cancer.
Pan S; Brentnall TA; Chen R
World J Gastroenterol; 2016 Nov; 22(42):9288-9299. PubMed ID: 27895417
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput Analyses of Glycans, Glycosites, and Intact Glycopeptides Using C4-and C18/MAX-Tips and Liquid Handling System.
Chen SY; Clark DJ; Zhang H
Curr Protoc; 2021 Jul; 1(7):e186. PubMed ID: 34232571
[TBL] [Abstract][Full Text] [Related]
15. Identification of O-Linked Glycoproteins Binding to the Lectin Helix pomatia Agglutinin as Markers of Metastatic Colorectal Cancer.
Peiris D; Ossondo M; Fry S; Loizidou M; Smith-Ravin J; Dwek MV
PLoS One; 2015; 10(10):e0138345. PubMed ID: 26495974
[TBL] [Abstract][Full Text] [Related]
16. Glycans and glycoproteins as specific biomarkers for cancer.
Kailemia MJ; Park D; Lebrilla CB
Anal Bioanal Chem; 2017 Jan; 409(2):395-410. PubMed ID: 27590322
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors.
Alvarez MRS; Zhou Q; Grijaldo SJB; Lebrilla CB; Nacario RC; Heralde FM; Rabajante JF; Completo GC
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744954
[TBL] [Abstract][Full Text] [Related]
18. Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells.
Burmi RS; Maginn EN; Gabra H; Stronach EA; Wasan HS
Cancer Biol Ther; 2019; 20(1):21-30. PubMed ID: 30261145
[TBL] [Abstract][Full Text] [Related]
19. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
20. Characterization of core fucosylation via sequential enzymatic treatments of intact glycopeptides and mass spectrometry analysis.
Cao L; Lih TM; Hu Y; Schnaubelt M; Chen SY; Zhou Y; Guo C; Dong M; Yang W; Eguez RV; Chen L; Clark DJ; Sodhi A; Li QK; Zhang H
Nat Commun; 2022 Jul; 13(1):3910. PubMed ID: 35798744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
